<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref-73">
 <label>73</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yada</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Nogami</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Kitazawa</surname>
    <given-names>T</given-names>
   </name>
   <etal/>
  </person-group>: 
  <article-title>Mode of Enhancement in the Global Hemostatic Potential with Concomitant Use of Bypassing Agents and Emicizumab in Hemophilia A Patients with Inhibitor Evaluated by Rotem</article-title>. Paper presented at: Congress of the International Society of Thrombosis and Haemostasis; Berlin, Germany.
  <year>2017</year>.
 </mixed-citation>
</ref>
